Our Mission
01
Genetic-Based Diagnostics
Alercell utilizes advancements in DNA sequencing and molecular diagnostics to identify genetic alterations that drive cancer development. This precision ensures accurate diagnosis and treatment planning.
02
Commitment to Research and Development
Innovation at Alercell is driven by continuous investment in R&D to explore novel genetic pathways, refine existing diagnostic tools, and pioneer new methods to combat cancer effectively.
03
Early genetic diagnostics open the door to theranostics interventions by identifying precise genetic abnormalities, enabling simultaneous personalized therapy and monitoring for optimized treatment outcomes.
04
Liquid Biopsy for Patient Comfort
Liquid biopsy makes sense for patients because it offers a minimally invasive, rapid, and accurate method to detect and monitor diseases, enabling early diagnosis and personalized treatment strategies.
05
Rapid and Accessible Testing
Our tests, such as Lena Q51 and Lena S1, deliver results within hours using standard qPCR equipment. This ensures patients and clinicians receive timely, reliable information for quicker decision-making.
06
Comprehensive Approach to Patient Care
By combining multiple diagnostic tests, Alercell provides a holistic view of a patient’s condition, enabling better decision-making for clinicians and personalized care for patients.
